Study Reveals Advantages of Non-Calcareous Phosphate Binders
Use of these agents is associated with a much lower incidence of hypercalcemia compared with the use of calcium carbonate or calcium acetate.
Kidney Week 2014 Hyperphosphatemia
Insulin Resistance Linked to High Phosphorus in Maintenance Hemodialysis (MHD) Patients
In adjusted analyses, serum phosphorus levels independently predicted glucose disposal rate.
Higher Phosphorus, Cardiovascular Disease (CVD) Not Linked in Kidney Disease (CKD) Patients
Each 0.5 mg/dL increment in serum phosphorus associated with 58% increased odds of coronary heart failure (CHF).
Ferric Citrate Phosphate Binder Cuts Hospitalization Rates
Rates for infection-, gastrointestinal-, and cardiac-related adverse events are lower than with sevelamer carbonate or calcium acetate.
Plant-Based Phosphorus Best for Kidney Disease (CKD) Patients
Plant-based diet had the lowest urinary phosphorus excretion, whereas an inorganic-based diet had the highest.
Extended Hemodialysis May Improve Phosphate Control
Researchers observe significant decline in serum phosphate levels with 6 hours vs. 4 hours of treatment.
Higher Phosphorus Levels Predict Increased Death Risk in Men
No association between phosphorus levels and all-cause mortality in women.
Elevated Phosphorus Levels Raise Risk of Kidney Failure
Every 1 mg/dL increase in serum phosphorus was independently associated with a 36% increased relative risk of kidney failure.
Hyperphosphatemia Raises Coronary Artery Calcification (CAC) Risk in Peritoneal Dialysis
Study of coronary artery calcification (CAC) risk also shows serum phosphorus levels associated with nutritional intake and dialysis adequacy.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Kidney Week 2014 Hyperphosphatemia
Loading... 
Loading...